Skip to main content
. Author manuscript; available in PMC: 2021 Sep 18.
Published in final edited form as: Inflamm Bowel Dis. 2014 Oct;20(10):1729–1733. doi: 10.1097/MIB.0000000000000134

FIGURE 3.

FIGURE 3.

IBD-related symptoms by type of hormonal contraceptive type in current and past users. Participants reporting different current and previous hormonal methods are counted for each method; therefore, the total n = number of contraceptive method exposures. DMPA, depot medroxyprogesterone acetate; implant, etonogestrel subdermal implant; LNG IUD, levonorgestrel intrauterine device; POP, progestin-only pills; P/P/R, combination estrogen and progestin pills, transdermal patch, or vaginal ring.